Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

PET of brain amyloid and tau in mild cognitive impairment.

Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.

N Engl J Med. 2006 Dec 21;355(25):2652-63.

2.

3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.

Apostolova LG, Lu PH, Rogers S, Dutton RA, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):224-31.

PMID:
17132966
3.

High-yield, automated radiosynthesis of 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile ([18F]FDDNP) ready for animal or human administration.

Liu J, Kepe V, Zabjek A, Petric A, Padgett HC, Satyamurthy N, Barrio JR.

Mol Imaging Biol. 2007 Jan-Feb;9(1):6-16.

PMID:
17051324
4.

Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.

Singh V, Chertkow H, Lerch JP, Evans AC, Dorr AE, Kabani NJ.

Brain. 2006 Nov;129(Pt 11):2885-93. Epub 2006 Sep 28.

PMID:
17008332
5.

[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease.

Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC.

Neurology. 2006 Aug 8;67(3):446-52.

PMID:
16894106
6.

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M, Zamora D, Goodkind M, Bell K, Stern Y, Devanand DP.

Arch Gen Psychiatry. 2006 Aug;63(8):916-24.

PMID:
16894068
7.
8.

Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.

Castellani RJ, Lee HG, Perry G, Smith MA.

Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):126-30. Review.

PMID:
16634469
9.

Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.

Watson D, Castaño E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES Jr, Esh C, Luehrs DC, Stine WB, Rowse LM, Emmerling MR, Roher AE.

Neurol Res. 2005 Dec;27(8):869-81. Review.

PMID:
16354549
10.

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA.

J Neurosci. 2005 Aug 24;25(34):7709-17.

11.

Tau, tangles, and Alzheimer's disease.

Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW.

Biochim Biophys Acta. 2005 Jan 3;1739(2-3):216-23. Review.

12.

In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Verhoeff NP, Wilson AA, Takeshita S, Trop L, Hussey D, Singh K, Kung HF, Kung MP, Houle S.

Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):584-95.

PMID:
15545326
13.

Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy.

Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC.

Cereb Cortex. 2005 Jul;15(7):995-1001. Epub 2004 Nov 10.

PMID:
15537673
14.

Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia.

Thompson PM, Hayashi KM, Sowell ER, Gogtay N, Giedd JN, Rapoport JL, de Zubicaray GI, Janke AL, Rose SE, Semple J, Doddrell DM, Wang Y, van Erp TG, Cannon TD, Toga AW.

Neuroimage. 2004;23 Suppl 1:S2-18. Review.

PMID:
15501091
15.

Longitudinal mapping of cortical thickness and brain growth in normal children.

Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW.

J Neurosci. 2004 Sep 22;24(38):8223-31.

16.

Mild cognitive impairment as a diagnostic entity.

Petersen RC.

J Intern Med. 2004 Sep;256(3):183-94. Review.

17.

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergström M, Savitcheva I, Huang GF, Estrada S, Ausén B, Debnath ML, Barletta J, Price JC, Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Långström B.

Ann Neurol. 2004 Mar;55(3):306-19.

PMID:
14991808
18.

A rating scale for depression.

HAMILTON M.

J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62. No abstract available.

19.

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Giannakopoulos P, Herrmann FR, Bussière T, Bouras C, Kövari E, Perl DP, Morrison JH, Gold G, Hof PR.

Neurology. 2003 May 13;60(9):1495-500.

PMID:
12743238
20.

Dynamics of gray matter loss in Alzheimer's disease.

Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM, Toga AW.

J Neurosci. 2003 Feb 1;23(3):994-1005.

Supplemental Content

Support Center